Animal Bioscience Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series AA

  • Latest Deal Amount
  • $2.32M

  • Investors
  • 1

Animal Bioscience General Information

Description

Developer of medical compounds and treatments designed to prolong youth and expand the lifespan of pets. The company develops clinically evaluated chewable supplements that act at the cellular level to slow functional deterioration and incorporates research-driven ingredient selection to address cardiovascular resilience, joint flexibility, cognitive maintenance, and overall metabolic balance, enabling pet owners and animal health professionals to support aging dogs with sustained vitality, reduced disease risk, and improved quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 361 Newbury Street
  • 5th Floor
  • Boston, MA 02115
  • United States
+1 (617)
Primary Industry
Other Services (B2C Non-Financial)
Vertical(s)
Corporate Office
  • 361 Newbury Street
  • 5th Floor
  • Boston, MA 02115
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Animal Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series AA) 08-Sep-2026 $2.32M Completed Product Development
2. Later Stage VC (Series A2) 07-Jan-2022 Completed Product Development
1. Seed Round 25-Sep-2020 $634K $634K Completed Product Development
To view Animal Bioscience’s complete valuation and funding history, request access »

Animal Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series AA4
Series AA3
Series AA2
Series AA1
Series A2 1,839,689 $0.000100 $1.63 $1.63 1x $1.31 24.51%
Series A 394,999 $0.000100 $0.51 $0.51 1x $0.49 4.39%
To view Animal Bioscience’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Animal Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical compounds and treatments designed to prolong youth and expand the lifespan of pets. The company dev
Other Services (B2C Non-Financial)
Boston, MA
4 As of 2026

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Animal Bioscience Competitors (1)

One of Animal Bioscience’s competitors is Loyal, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Loyal Venture Capital-Backed San Francisco, CA
You’re viewing 1 of 1 competitors. Get the full list »

Animal Bioscience Patents

Animal Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022258448-A1 Formulations of nicotinic acid derivatives and flavonoid polyphenols and uses thereof Pending 13-Apr-2021
CA-3215014-A1 Formulations of nicotinic acid derivatives and flavonoid polyphenols and uses thereof Pending 13-Apr-2021
EP-4322932-A1 Formulations of nicotinic acid derivatives and flavonoid polyphenols and uses thereof Pending 13-Apr-2021
EP-4322932-A4 Formulations of nicotinic acid derivatives and flavonoid polyphenols and uses thereof Pending 13-Apr-2021
US-20230302033-A1 Formulations of nicotinic acid derivatives and flavonoid polyphenols and uses thereof Pending 13-Apr-2021 A61K31/352
To view Animal Bioscience’s complete patent history, request access »

Animal Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Animal Bioscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Longevitytech.fund Venture Capital Minority
To view Animal Bioscience’s complete investors history, request access »

Animal Bioscience FAQs

  • When was Animal Bioscience founded?

    Animal Bioscience was founded in 2017.

  • Where is Animal Bioscience headquartered?

    Animal Bioscience is headquartered in Boston, MA.

  • What is the size of Animal Bioscience?

    Animal Bioscience has 4 total employees.

  • What industry is Animal Bioscience in?

    Animal Bioscience’s primary industry is Other Services (B2C Non-Financial).

  • Is Animal Bioscience a private or public company?

    Animal Bioscience is a Private company.

  • What is the current valuation of Animal Bioscience?

    The current valuation of Animal Bioscience is .

  • What is Animal Bioscience’s current revenue?

    The current revenue for Animal Bioscience is .

  • How much funding has Animal Bioscience raised over time?

    Animal Bioscience has raised $4.95M.

  • Who are Animal Bioscience’s investors?

    Longevitytech.fund has invested in Animal Bioscience.

  • Who are Animal Bioscience’s competitors?

    Loyal is a competitor of Animal Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process